Biotech Values

[mcbio]

Re: PCYC

I'd be amazed if anyone bought $24m worth of this crummy company. Seems like they are suffering from a pretty big bout of hubris.

They are pretty much out of cash - just let them die and by the IP out of bankruptcy.

I am by no means about to pull the trigger on an investment in PCYC as the company has had plenty of problems in the past, but I think the stock could be worth a look a little later down the road namely for its early-stage Btk inhibitors (http://investorshub.advfn.com/boards/read_msg.aspx?message_id=36998377&txt2find=pcyc ). There is big potential for an oral compound that can treat RA, among other indications. And that's one of the reasons why I'm in RIGL at the moment. I want to see PCYC demonstrate initial PoC and find a partner for the program; but, if they can do that, and the stock has not appreciated substantially from current levels, I think it could be worth a look.